Your browser doesn't support javascript.
loading
The Sara Combilizer® as an early mobilisation aid for critically ill patients: A prospective before and after study.
McWilliams, David; Atkins, Gemma; Hodson, James; Snelson, Catherine.
Affiliation
  • McWilliams D; Therapy Services, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: David.Mcwilliams@uhb.nhs.uk.
  • Atkins G; Therapy Services, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom.
  • Hodson J; Medical Statistician, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom.
  • Snelson C; Critical Care, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom.
Aust Crit Care ; 30(4): 189-195, 2017 Jul.
Article de En | MEDLINE | ID: mdl-27745753
ABSTRACT

BACKGROUND:

Early mobility within the ICU is associated with a number of positive outcomes including reductions in ICU and hospital length of stay and better functional recovery. The exact definition of 'early' mobility is still not defined, with the actual ability to mobilise limited by a number of perceived factors. The Sara Combilizer® is a combined tilt table and stretcher chair, which allows passive transfer of patients out of bed. This study aimed to assess whether the introduction of the Sara Combilizer® reduced time taken to first mobilise for patients mechanically ventilated for at least five days and at risk of ICU acquired weakness.

METHODS:

Patients admitted to a large UK critical care unit during the trial period and ventilated for ≥5days were included in the study. Baseline data was collected prospectively for a period of four months. The Sara Combilizer® was then introduced for a one month training and familiarisation period, followed by a further four months prospective data collection. The primary outcome was time to first mobilisation, defined as a Manchester Mobility Score ≥2.

RESULTS:

Following the introduction of the Sara Combilizer®, time taken to mobilise reduced significantly from 13.6 to 10.6days (p=0.028). SOFA scores were significantly higher at the point of first mobilisation in the Combilizer group (mean 2.9±0.5 vs. 5.1±2.4; p=0.005). There was no statistical difference in therapy time between the groups, or ICU or hospital length of stay.

CONCLUSIONS:

The introduction of the Sara Combilizer® was associated with a significant reduction in time to mobilise patients ventilated for ≥5days, and patients were mobilised with a higher degree of organ failure. This was achieved without any increase in therapy time. The Sara Combilizer® may be a useful adjunct to an early mobility protocol within the ICU.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie grave / Lever précoce / Lever et mobilisation de patient / Unités de soins intensifs Type d'étude: Guideline / Observational_studies / Risk_factors_studies Limites: Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Aust Crit Care Sujet du journal: ENFERMAGEM / TERAPIA INTENSIVA Année: 2017 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie grave / Lever précoce / Lever et mobilisation de patient / Unités de soins intensifs Type d'étude: Guideline / Observational_studies / Risk_factors_studies Limites: Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Aust Crit Care Sujet du journal: ENFERMAGEM / TERAPIA INTENSIVA Année: 2017 Type de document: Article